303 related articles for article (PubMed ID: 19805508)
1. Pharmacological removal of human ether-à-go-go-related gene potassium channel inactivation by 3-nitro-N-(4-phenoxyphenyl) benzamide (ICA-105574).
Gerlach AC; Stoehr SJ; Castle NA
Mol Pharmacol; 2010 Jan; 77(1):58-68. PubMed ID: 19805508
[TBL] [Abstract][Full Text] [Related]
2. 2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD-307243) causes instantaneous current through human ether-a-go-go-related gene potassium channels.
Gordon E; Lozinskaya IM; Lin Z; Semus SF; Blaney FE; Willette RN; Xu X
Mol Pharmacol; 2008 Mar; 73(3):639-51. PubMed ID: 18042732
[TBL] [Abstract][Full Text] [Related]
3. Electrophysiologic characterization of a novel hERG channel activator.
Su Z; Limberis J; Souers A; Kym P; Mikhail A; Houseman K; Diaz G; Liu X; Martin RL; Cox BF; Gintant GA
Biochem Pharmacol; 2009 Apr; 77(8):1383-90. PubMed ID: 19426677
[TBL] [Abstract][Full Text] [Related]
4. Cardiac glycosides as novel inhibitors of human ether-a-go-go-related gene channel trafficking.
Wang L; Wible BA; Wan X; Ficker E
J Pharmacol Exp Ther; 2007 Feb; 320(2):525-34. PubMed ID: 17095614
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of berberine on IK1, IK, and HERG channels of cardiac myocytes.
Li BX; Yang BF; Zhou J; Xu CQ; Li YR
Acta Pharmacol Sin; 2001 Feb; 22(2):125-31. PubMed ID: 11741516
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological activation of rapid delayed rectifier potassium current suppresses bradycardia-induced triggered activity in the isolated guinea pig heart.
Hansen RS; Olesen SP; Grunnet M
J Pharmacol Exp Ther; 2007 Jun; 321(3):996-1002. PubMed ID: 17325228
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human ether-a-go-go-related gene K+ channel and IKr of guinea pig cardiomyocytes by antipsychotic drug trifluoperazine.
Choi SY; Koh YS; Jo SH
J Pharmacol Exp Ther; 2005 May; 313(2):888-95. PubMed ID: 15722405
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of coronary vasodilator papaverine on heterologously-expressed HERG currents in Xenopus oocytes.
Kim CS; Lee N; Son SJ; Lee KS; Kim HS; Kwak YG; Chae SW; Lee SD; Jeon BH; Park JB
Acta Pharmacol Sin; 2007 Apr; 28(4):503-10. PubMed ID: 17376289
[TBL] [Abstract][Full Text] [Related]
9. Molecular interaction of droperidol with human ether-a-go-go-related gene channels: prolongation of action potential duration without inducing early afterdepolarization.
Schwoerer AP; Blütner C; Brandt S; Binder S; Siebrands CC; Ehmke H; Friederich P
Anesthesiology; 2007 May; 106(5):967-76. PubMed ID: 17457128
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a small molecule activator of the human ether-a-go-go-related gene (HERG) cardiac K+ channel.
Kang J; Chen XL; Wang H; Ji J; Cheng H; Incardona J; Reynolds W; Viviani F; Tabart M; Rampe D
Mol Pharmacol; 2005 Mar; 67(3):827-36. PubMed ID: 15548764
[TBL] [Abstract][Full Text] [Related]
11. Block of hERG K+ channel and prolongation of action potential duration by fluphenazine at submicromolar concentration.
Hong HK; Lee BH; Park MH; Lee SH; Chu D; Kim WJ; Choe H; Hee Choi B; Jo SH
Eur J Pharmacol; 2013 Feb; 702(1-3):165-73. PubMed ID: 23395964
[TBL] [Abstract][Full Text] [Related]
12. Development of recombinant cell line co-expressing mutated Nav1.5, Kir2.1, and hERG for the safety assay of drug candidates.
Fujii M; Ohya S; Yamamura H; Imaizumi Y
J Biomol Screen; 2012 Jul; 17(6):773-84. PubMed ID: 22498908
[TBL] [Abstract][Full Text] [Related]
13. Alteration of HERG current profile during the cardiac ventricular action potential, following a pore mutation.
Hancox JC; Witchel HJ; Varghese A
Biochem Biophys Res Commun; 1998 Dec; 253(3):719-24. PubMed ID: 9918793
[TBL] [Abstract][Full Text] [Related]
14. Mallotoxin is a novel human ether-a-go-go-related gene (hERG) potassium channel activator.
Zeng H; Lozinskaya IM; Lin Z; Willette RN; Brooks DP; Xu X
J Pharmacol Exp Ther; 2006 Nov; 319(2):957-62. PubMed ID: 16928897
[TBL] [Abstract][Full Text] [Related]
15. Electrophysiological characterization of a small molecule activator on human ether-a-go-go-related gene (hERG) potassium channel.
Dong X; Liu Y; Niu H; Wang G; Dong L; Zou A; Wang K
J Pharmacol Sci; 2019 Jul; 140(3):284-290. PubMed ID: 31481348
[TBL] [Abstract][Full Text] [Related]
16. Blockade of the human ether-a-go-go-related gene potassium channel by ketanserin.
Tu DN; Zou AR; Liao YH; Du YM; Wang XP; Li L
Sheng Li Xue Bao; 2008 Aug; 60(4):525-34. PubMed ID: 18690396
[TBL] [Abstract][Full Text] [Related]
17. HIV Tat protein inhibits hERG K+ channels: a potential mechanism of HIV infection induced LQTs.
Bai YL; Liu HB; Sun B; Zhang Y; Li Q; Hu CW; Zhu JX; Gong DM; Teng X; Zhang Q; Yang BF; Dong DL
J Mol Cell Cardiol; 2011 Nov; 51(5):876-80. PubMed ID: 21820442
[TBL] [Abstract][Full Text] [Related]
18. Clemastine, a conventional antihistamine, is a high potency inhibitor of the HERG K+ channel.
Ridley JM; Milnes JT; Hancox JC; Witchel HJ
J Mol Cell Cardiol; 2006 Jan; 40(1):107-18. PubMed ID: 16288909
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of AMP 579, a novel cardioprotective adenosine A1/A2A receptor agonist, on native IKr and cloned HERG current.
Saegusa N; Sato T; Ogura T; Komuro I; Nakaya H
Naunyn Schmiedebergs Arch Pharmacol; 2004 Dec; 370(6):492-9. PubMed ID: 15558241
[TBL] [Abstract][Full Text] [Related]
20. Blockade of HERG cardiac K+ current by antifungal drug miconazole.
Kikuchi K; Nagatomo T; Abe H; Kawakami K; Duff HJ; Makielski JC; January CT; Nakashima Y
Br J Pharmacol; 2005 Mar; 144(6):840-8. PubMed ID: 15778703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
